Kazuaki Teshima
Yokote, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Successful Re-administration of Granulocyte Colony-Stimulating Factor Without Recurrence of Associated Vasculitis: A Case Report.
Journal: Cureus
Published: October 22, 2025
Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia.
Journal: Cancer chemotherapy and pharmacology
Published: January 22, 2024
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.
Journal: International journal of clinical oncology
Published: September 27, 2023
Acute Myeloid Leukemia Harboring the t(16;21)(p11;q22) Translocation Treated With Venetoclax Plus Azacitidine After Cord Blood Transplantation.
Journal: Cureus
Published: July 20, 2023
Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia.
Journal: Internal medicine (Tokyo, Japan)
Published: February 01, 2021
CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal Tumor.
Journal: Case reports in hematology
Published: December 06, 2019
Refractory CD20-positive peripheral T-cell lymphoma showing loss of CD20 expression after rituximab therapy and gain of CD20 expression after administration of vorinostat and gemcitabine
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 08, 2017
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma.
Journal: Cancer science
Published: November 05, 2016
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Journal: Oncotarget
Published: September 24, 2016
Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Journal: Modern rheumatology
Published: March 17, 2015
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Journal: Blood
Published: January 04, 2014
Last Updated: 09/26/2026